GlassScriptPhysician profile
Reginald L Madden
NPI 1265464903
$4,085.69
in general payments reported to CMS, 2019-2025
19 companies · $473 in 2025
The $473 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,022 · 2022: $954 · 2023: $886 · 2024: $750 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,109.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,253.52 | 2021-2025 | Lifevest |
| Amgen INC. | $501.67 | 2021-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $472.87 | 2021-2024 | |
| Boston Scientific Corporation | $471.40 | 2021-2024 | Watchman Flx, Ekosonic |
| Janssen Pharmaceuticals, INC | $410.40 | 2021-2024 | Xarelto |
| Pfizer INC. | $182.88 | 2022-2025 | |
| Esperion Therapeutics, INC. | $169.36 | 2021-2023 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $126.54 | 2021-2025 | Jardiance |
| Abiomed | $92.86 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $72.30 | 2021-2022 | |
| Novo Nordisk INC | $61.17 | 2025 | Wegovy |
| Impulse Dynamics (USA) INC. | $54.79 | 2023 | Optimizer |
| Celgene Corporation | $54.13 | 2022-2024 | Camzyos |
| Abbott Laboratories | $50.00 | 2025 | Mitraclip, Triclip |
| Gilead Sciences, INC. | $27.63 | 2021-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $26.20 | 2023 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $20.86 | 2022 | |
| Medtronic, INC. | $19.60 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $17.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reginald Madden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.